Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
The-0504 in Small Cell Lung Cancer: NCT07646106 Clinical Landscape Report 2026
16 September 2026
NCT07646106 clinical landscape for Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sparfosic acid in Dermatitis, Atopic: CTRI/2026/06/112360 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/06/112360 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tapinarof in Plaque psoriasis: NCT07635043 Clinical Landscape Report 2026
16 September 2026
NCT07635043 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tofacitinib Citrate in Psoriasis vulgaris: CTRI/2026/06/112460 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/06/112460 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Teclistamab in Multiple Myeloma: NCT07638683 Clinical Landscape Report 2026
16 September 2026
NCT07638683 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ALK.CAR-T cells(University of Turin/Boston Children) in Metastatic Clear Cell Renal Cell Carcinoma: NCT07645690 Clinical Landscape Report 2026
16 September 2026
NCT07645690 clinical landscape for Metastatic Clear Cell Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Bevacizumab in Metastatic Carcinoma to the Uterine Cervix: NCT07645625 Clinical Landscape Report 2026
16 September 2026
NCT07645625 clinical landscape for Metastatic Carcinoma to the Uterine Cervix: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Azacitidine in Acute Myeloid Leukemia: NCT07645469 Clinical Landscape Report 2026
16 September 2026
NCT07645469 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gentamicin Sulfate in Urinary Bladder, Neurogenic: NCT07643974 Clinical Landscape Report 2026
16 September 2026
NCT07643974 clinical landscape for Urinary Bladder, Neurogenic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Clofarabine in Acute Myeloid Leukemia: NCT07644481 Clinical Landscape Report 2026
16 September 2026
NCT07644481 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sintilimab in Sarcoma: NCT07648069 Clinical Landscape Report 2026
16 September 2026
NCT07648069 clinical landscape for Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CHT-101 in Metastatic Renal Cell Carcinoma: NCT07647744 Clinical Landscape Report 2026
16 September 2026
NCT07647744 clinical landscape for Metastatic Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.